MedPath

Prophylactic Magnesium Sulfate and Sepsis in Preterm neonates

Phase 1
Recruiting
Conditions
respiratory distress syndrome.
Respiratory distress syndrome of newborn
P22.0
Registration Number
IRCT20080901001162N28
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
194
Inclusion Criteria

Premature newborns 28 to 34 weeks weighing 1200 to 2000 grams with respiratory distress syndrome
Informed consent

Exclusion Criteria

Intake of magnesium sulfate by the mother during pregnancy
Neonatal anomaly
Chorioamnionitis
Mother's disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The days requiring assisted ventilation ( need for invasive or non-invasive assisted ventilation). Timepoint: During the hospitalization of the newborn. Method of measurement: daily It is done only through a mask that is firmly placed on the face.
Secondary Outcome Measures
NameTimeMethod
Âİ Copyright 2025. All Rights Reserved by MedPath